Last reviewed · How we verify
NCT05658718
Factors Influencing Nocturnal Symptoms After Refractive Surgery.
trial testing refractive surgery in Refractive Surgery in 400 participants. Status unknown.
1 December 2023
Quick facts
| Lead sponsor | Second Affiliated Hospital of Nanchang University |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 400 |
| Start date | 1 November 2021 |
| Primary completion | 1 December 2023 |
| Estimated completion | 1 December 2023 |
| Sites | 1 location across China |
Drugs / interventions tested
- refractive surgery
Conditions studied
- Refractive Surgery — all drugs for Refractive Surgery →
- Visual Quality — all drugs for Visual Quality →
Sponsor
Second Affiliated Hospital of Nanchang University
Who can join
Adults 18 to 45, any sex, with Refractive Surgery or Visual Quality. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
By comparing the parameters of the two groups of patients with glare at night after refractive surgery and those without glare at night, the influence of preoperative related parameters on postoperative glare was analyzed.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Mesopic pupil indices as potential risk factors for glare disability after intraocular implantable collamer lens implantation: prospective study.
Xiong J, Xu J, Zhou M, Liu J, et al · · 2024 · cited 1× · PMID 38350161 · DOI 10.1097/j.jcrs.0000000000001420
Verify or expand the search:
- PubMed search for NCT05658718
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Refractive Surgery
Currently open trials in the same condition.
- NCT07481487 — Outcomes of Cataract & Refractive Procedures · recruiting
- NCT07146828 — Clinical Application Research of 5-Degree (0.05 D) Precision Optometry in Corneal Refractive Surgery · NA · recruiting
- NCT06982807 — Clinical Study of SMILE 4.0-VISULYZE in Correcting Refractive Errors · NA · recruiting
- NCT06448468 — Analysis of Ocular Surface Microbiota in Dry Eye Patients After Femtosecond Laser-assisted In-situ Keratomileusis (FS-LA · recruiting
- NCT06264804 — Risk Factors for Progressive Suction Loss in Corneal Refractive Surgery · recruiting
Other Second Affiliated Hospital of Nanchang University trials
Trials by the same sponsor.
- NCT07346794 — The Underlying Neural Mechanism of TMS in Improving the Imbalance of "Microbiota-brain-gut Axis" in Alzheimer 's Disease · NA · not yet recruiting
- NCT07398599 — Double-Dose Third-Generation EGFR-TKI Plus Bevacizumab and Intrathecal Chemotherapy for Refractory Leptomeningeal Metast · NA · recruiting
- NCT07401784 — Efficacy and Safety Evaluation of Remote Ischemic Adaptation ( Intermittent Pressure Stimulation ) in the Treatment of I · NA · not yet recruiting
- NCT07290699 — Intensive Cholesterol-Lowering Within 24 Hours of PCI Perioperative Period · Phase 4 · not yet recruiting
- NCT07295444 — A Clinical Study Evaluating the Efficacy and Safety of CreNeuriS CNS Herbal Nutrition Capsules for Participants With Mil · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05658718 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Second Affiliated Hospital of Nanchang University
- Last refreshed: 7 September 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05658718.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing